Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta: A cohort study
- PMID: 30496259
- PMCID: PMC6264507
- DOI: 10.1371/journal.pone.0208139
Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta: A cohort study
Abstract
Objective: To evaluate ovarian reserve in women after preservative cesarean delivery using uterine artery embolization due to morbidly adherent placenta.
Study design: A historical cohort study including all women admitted to a single tertiary care center, with morbidly adherent placenta that had preservative cesarean delivery with bilateral uterine artery embolization. Inclusion criteria included gestational age >24 weeks, singleton pregnancy and placenta increta / percreta. Exclusion criteria included maternal age > 43 years old and cesarean hysterectomy. Control group included women attending the infertility clinic due to male factor or single women conceiving via sperm donation, matched by age. Blood samples were collected on day 2-5 of menstruations for hormonal profile and Anti Mullarian Hormone (AMH) levels. Primary outcome was ovarian reserve evaluated by the levels of AMH.
Results: 59 women underwent preservative cesarean delivery using uterine artery embolization during the study period. 21 women met inclusion criteria (33.9%) and were matched controls (n = 40). Circulating levels of E2 and FSH did not differ significantly between the two groups (p = 0.665, p = 0.396, respectively). AMH was lower in the study group (median 0.8 IQR 0.44-1.80) compared to the controls (median 2.08 IQR 1.68-3.71) (p = 0.001). This finding was consistent in linear multivariate regression analysis where the group of cesarean delivery using bilateral artery embolization due to placenta accrete was significantly predictive for the levels of AMH (B = -1.308, p = 0.012).
Conclusion: Women post preservative cesarean delivery using uterine artery embolization due to placenta accrete have lower ovarian reserve compare to controls matched by age.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder-A comparative study.Acta Obstet Gynecol Scand. 2020 Oct;99(10):1374-1380. doi: 10.1111/aogs.13868. Epub 2020 May 20. Acta Obstet Gynecol Scand. 2020. PMID: 32282925
-
Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.Am J Obstet Gynecol. 2021 Oct;225(4):442.e1-442.e10. doi: 10.1016/j.ajog.2021.07.001. Epub 2021 Jul 7. Am J Obstet Gynecol. 2021. PMID: 34245679
-
Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization.Acta Obstet Gynecol Scand. 2013 Nov;92(11):1250-5. doi: 10.1111/aogs.12230. Epub 2013 Sep 7. Acta Obstet Gynecol Scand. 2013. PMID: 23937444
-
The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis.Acta Obstet Gynecol Scand. 2020 Jan;99(1):16-23. doi: 10.1111/aogs.13698. Epub 2019 Aug 26. Acta Obstet Gynecol Scand. 2020. PMID: 31370100
-
Conservative management of morbidly adherant placenta - a case report and review of literature.Placenta. 2013 Oct;34(10):963-6. doi: 10.1016/j.placenta.2013.04.016. Epub 2013 Aug 12. Placenta. 2013. PMID: 23937959 Review.
Cited by
-
Knowledge of iatrogenic premature ovarian insufficiency among Chinese obstetricians and gynaecologists: a national questionnaire survey.J Ovarian Res. 2020 Nov 18;13(1):134. doi: 10.1186/s13048-020-00739-z. J Ovarian Res. 2020. PMID: 33208171 Free PMC article.
-
Prophylactic Intraoperative Uterine Artery Embolization During Cesarean Section or Cesarean Hysterectomy in Patients with Abnormal Placentation: A Systematic Review and Meta-Analysis.Cardiovasc Intervent Radiol. 2022 Apr;45(4):488-501. doi: 10.1007/s00270-021-02921-2. Epub 2021 Jul 19. Cardiovasc Intervent Radiol. 2022. PMID: 34282489
-
Scar Ectopic Pregnancy as an Uncommon Site of Ectopic Pregnancy: A Case Report and Literature Review.Life (Basel). 2023 Oct 31;13(11):2151. doi: 10.3390/life13112151. Life (Basel). 2023. PMID: 38004291 Free PMC article.
-
Laparoscopic hemostasis and drainage for postpartum retroperitoneal hematoma complicated with an infection: A case report and surgical video.Ann Med Surg (Lond). 2022 Apr 28;77:103686. doi: 10.1016/j.amsu.2022.103686. eCollection 2022 May. Ann Med Surg (Lond). 2022. PMID: 35638002 Free PMC article.
References
-
- Su HW, Yi YC, Tseng JJ, Chen WC, Chen YF, Kung HF, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353–7. 10.1016/j.tjog.2017.04.016 - DOI - PubMed
-
- Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol. 2009;33(2):88–96. 10.1053/j.semperi.2008.12.003 - DOI - PubMed
-
- Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4):927–41. 10.1097/01.AOG.0000207559.15715.98 - DOI - PubMed
-
- Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208(3):219.e1-7. - PubMed
-
- Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–54. 10.1111/j.1471-0528.2008.02037.x - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous